These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36936866)

  • 21. Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report.
    Vallerand IA; Hardin J
    SAGE Open Med Case Rep; 2019; 7():2050313X19845206. PubMed ID: 31080598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spesolimab: A Novel Treatment for Pustular Psoriasis.
    Ratnarajah K; Jfri A; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(2):199-200. PubMed ID: 32208020
    [No Abstract]   [Full Text] [Related]  

  • 23. Pyoderma gangrenosum associated with Takayasu's arteritis in a young Caucasian woman and response to biologic therapy with tocilizumab.
    Choong DJ; Ng JL; Vinciullo C
    JAAD Case Rep; 2021 Mar; 9():4-6. PubMed ID: 33598515
    [No Abstract]   [Full Text] [Related]  

  • 24. Fatal pyoderma gangrenosum with pathergy after coronary artery bypass grafting.
    Bryan CS
    Tex Heart Inst J; 2012; 39(6):894-7. PubMed ID: 23304049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors.
    Maçães CO; Lé AM; Torres T
    J Dermatolog Treat; 2022 Nov; 33(7):2911-2918. PubMed ID: 35695278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current management of generalized pustular psoriasis.
    Kodali N; Blanchard I; Kunamneni S; Lebwohl MG
    Exp Dermatol; 2023 Aug; 32(8):1204-1218. PubMed ID: 36779681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyoderma gangrenosum associated with subcorneal pustular dermatosis and IgA myeloma.
    Ahmad K; Ramsay B
    Clin Exp Dermatol; 2009 Jan; 34(1):46-8. PubMed ID: 18627386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PG-TIME: A practical approach to the clinical management of pyoderma gangrenosum.
    Janowska A; Oranges T; Fissi A; Davini G; Romanelli M; Dini V
    Dermatol Ther; 2020 May; 33(3):e13412. PubMed ID: 32291879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative Pyoderma Gangrenosum: A Clinical Review of Published Cases.
    Tolkachjov SN; Fahy AS; Cerci FB; Wetter DA; Cha SS; Camilleri MJ
    Mayo Clin Proc; 2016 Sep; 91(9):1267-79. PubMed ID: 27489052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoinflammatory process in the pathogenesis of generalized pustular psoriasis and perspectives of its targeted therapy.
    Javor J; Buc M; Bucová M
    Epidemiol Mikrobiol Imunol; 2021; 70(3):199-207. PubMed ID: 34641694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis.
    Niv D; Ramirez JA; Fivenson DP
    JAAD Case Rep; 2017 Jan; 3(1):70-73. PubMed ID: 28203623
    [No Abstract]   [Full Text] [Related]  

  • 32. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review.
    Huang J; Tsang LS; Shi W; Li J
    Front Med (Lausanne); 2022; 9():856786. PubMed ID: 35402426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of disease burden and clinical management for generalized pustular psoriasis in China.
    Lu J; Shi Y
    Expert Rev Clin Immunol; 2022 Oct; 18(10):1023-1032. PubMed ID: 36040447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Case of the Co-Existence of Subcorneal Pustular Dermatosis and Pyoderma Gangrenosum and a Review of the Literature.
    Ferrillo M; Villani A; Fabbrocini G; Mascolo M; Megna M; Costa C; Napolitano M
    Open Access Maced J Med Sci; 2018 Jul; 6(7):1271-1274. PubMed ID: 30087735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis.
    Xia FD; Liu K; Lockwood S; Butler D; Tsiaras WG; Joyce C; Mostaghimi A
    J Am Acad Dermatol; 2018 Feb; 78(2):310-314.e1. PubMed ID: 28947285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of interleukin-1β in pyoderma gangrenosum.
    Galimberti RL; Vacas AS; Bollea Garlatti ML; Torre AC
    JAAD Case Rep; 2016 Sep; 2(5):366-368. PubMed ID: 27709123
    [No Abstract]   [Full Text] [Related]  

  • 38. Biologic and small-molecule medications in the management of pyoderma gangrenosum.
    McKenzie F; Cash D; Gupta A; Cummings LW; Ortega-Loayza AG
    J Dermatolog Treat; 2019 May; 30(3):264-276. PubMed ID: 30051737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyoderma Gangrenosum after Breast Mammoplasty Surgery: A Case Report.
    Fong CW; Tong SS; Pon M; Lai YF
    World J Plast Surg; 2021 May; 10(2):103-106. PubMed ID: 34307106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Pediatric Pyoderma Gangrenosum With Modified Negative Pressure Wound Therapy and Intralesional Corticosteroids: A Case Report.
    Barker CS; Santa Lucia G; Brunette G; Wine Lee L
    J Wound Ostomy Continence Nurs; 2022 Sep-Oct 01; 49(5):488-491. PubMed ID: 36108234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.